(Q41180804)

27 September 2017

title

The future of pharmacy: pharmaceutical care (English)

1 reference

27 September 2017

Hepler CD

1

1 reference

27 September 2017

publication date

1 October 1990

1 reference

27 September 2017

1 reference

27 September 2017

volume

NS30

1 reference

27 September 2017

issue

10

1 reference

27 September 2017

page(s)

23-29

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

27 September 2017

1 reference

7 January 2021

Letter: Preventability of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

The role of iatrogenic disease in admissions to intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

The role of drug-induced illness in admissions to an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

Hospital admissions caused by iatrogenic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

Preventable deaths: who, how often, and why?

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

What is the cost of nephrotoxicity associated with aminoglycosides?

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

Norfloxacin and absorption of magnesium-aluminum

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2816%2933605-4

7 January 2021

10.1016/S0160-3450(16)33605-4

Identifiers

DOI

0 references

1 reference